Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InPACT - International Penile Advanced Cancer Trial (International Rare Cancer Initiative)
2015-001199-23Phase 3Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of paclitaxel, ifosfamide and cisplatin in penile squamous cell carcinoma (PSCC), sponsored by The Institute of Cancer Research. Primary endpoint: Overall survival. Status: unknown.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
penile squamous cell carcinoma (PSCC)
Beyond the preview
Go deeper on 2015-001199-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001199-23.